NULYTELY
LOE Approachingpolyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride
NDAORALFOR SOLUTION
Approved
Apr 1991
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
NULYTELY (polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride) by R-Pharm US is osmotic activity [moa]. First approved in 1991.
Drug data last refreshed 15h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NULYTELY is an oral osmotic laxative solution containing polyethylene glycol 3350 with electrolytes, used for bowel preparation prior to colonoscopy and other GI procedures. It works through osmotic activity to draw water into the intestinal lumen, promoting evacuation of bowel contents. This is a standard-of-care, non-absorbed bowel cleansing agent.
$0.002BPart D
LOE ApproachingProduct is in late-stage lifecycle with minimal Medicare spending, indicating a mature, commoditized market with limited commercial team expansion opportunities.
Mechanism of Action
Osmotic Activity
Pharmacologic Class:
Osmotic Laxative
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on NULYTELY offers stability in a mature, low-growth product but limited visibility for career acceleration; roles emphasize cost containment, market access, and operational efficiency rather than innovation. This is a suitable assignment for professionals seeking steady work in a commoditized therapeutic category but offers minimal opportunity for high-impact brand building or clinical development.
Brand Manager
Worked on NULYTELY at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.